Adrian D Cook

6PUBLICATIONS
64CO-AUTHORS
Epidemiological methodsPredictive and prognostic markersPharmacogenomicsQuery processing and optimisationCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 11, 2026
Surgical waiting times in patients with high- and low-risk renal cell carcinoma in England.

|Jun 07, 2022
Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial.

Chris C Parker, Nicholas D James, Christopher D Brawley

|Apr 12, 2022
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476).

Nicholas D James, Noel W Clarke, Adrian Cook

|Sep 18, 2020
Overlap between adverse events (AEs) and serious adverse events (SAEs): a case study of a phase III cancer clinical trial.

Elizabeth C James, David Dunn, Adrian D Cook

|Mar 25, 2017
Quality of life with cediranib in relapsed ovarian cancer: The ICON6 phase 3 randomized clinical trial.

Dan P Stark, Adrian Cook, Julia M Brown

Pageof 1

Frequent Collaborators

3 joint publications

Matthew R Sydes

2 joint publications

Nicholas D James

2 joint publications

David Matheson

2 joint publications

Hannah Rush